Q&A: FDA med­ical pol­i­cy chief talks de­cen­tral­ized tri­al guid­ance, im­prov­ing di­ver­si­ty

The FDA’s di­rec­tor of its Of­fice of Med­ical Pol­i­cy wants tri­al spon­sors to keep par­tic­i­pant ex­pe­ri­ences top-of-mind in their de­cen­tral­ized de­signs.

End­points News sat down …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER